ENDOMETRIAL CANCER METASTATIC

Clinical trials for ENDOMETRIAL CANCER METASTATIC explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CANCER METASTATIC trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take on advanced cancers in early trial

Disease control Recruiting now

This early-phase trial tests a new treatment called p95HER2.CAR-TECH2Me for people with advanced HER2-positive cancers (breast, stomach, or endometrial cancer that has spread). The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and at…

Matched conditions: ENDOMETRIAL CANCER METASTATIC

Phase: PHASE1 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control

Last updated May 26, 2026 05:34 UTC

ENDOMETRIAL CANCER METASTATIC

Get alerted when new ENDOMETRIAL CANCER METASTATIC trials appear

Engineered immune cells take on advanced cancers in early trial